Michael Gorenstein appointed CEO of PharmaCan Capital
PharmaCan Capital Corp, a merchant bank that invests in the Canadian medical marijuana industry, has appointed Michael Gorenstein as its president and CEO, replacing Paul Rosen, who has resigned. Gorenstein, who has served as vice-chairman of PharmaCan, is a partner at Alphabet Ventures, a New York-based investment management firm. Toronto-based PharmaCan also announced the close of the first tranche of a $6 million private placement deal.
18 May 2016•4 mins read
